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Background. One of the strategies to reduce maternal mortality includes accessible and appropriate contraceptive services to all women. 
The intrauterine contraceptive device (IUCD) has been identified as a cheap and effective means of contraception by the South African 
National Department of Health.
Objective. To explore knowledge about the IUCD among women using the public health sector and identify any misconceptions.
Methods. A sample of 150 women attending antenatal/postnatal clinics were interviewed using a structured questionnaire.
Results. Forty-six percent (n=69) had some experience with the injectable form of contraception, and 2.7% (n=4) had used the IUCD; 
70.7% (n=106) knew that the device does not prevent HIV transmission, 40.7% (n=61) knew that HIV-positive women can use the IUCD, 
75.3% (n=113) believed that the IUCD causes heavy bleeding, 36.7% (n=55) knew that the device does not stop fertility indefinitely, 33.3% 
(n=50) knew that the IUCD can be inserted in the immediate postpartum period, and 26.7% (n=40) knew that the duration of use is 10 
years. In terms of attitudes, 40.0% (n=60) expressed concern about the pain during insertion, 33.3% (n=50) believed the IUCD can cause 
cancer, and 32.0% (n=48) believed that the device interferes with normal sexual activity. Most participants 77.3% (n=116) acquired the 
information they had about the IUCD from the clinic during teaching and counselling sessions.
Conclusion. This survey documented poor knowledge about the IUCD among women using the public health sector. However, the fact that 
there are few misconceptions and that clients rely on the clinic information should be seen as an opportunity to improve the situation. 
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The rate of unplanned pregnancies remains high 
worldwide, including in South Africa (SA). Despite 
reported high contraceptive use, nearly 40% of 
women are at risk of unintended pregnancy.[1] In 2008 
Frost and Darroch[2] reported that 38% of participants 
in their study had missed at least one active pill in the previous 3 
months, and pregnancies among contraceptive users accounted for 
nearly half of all unintended pregnancies and were almost entirely 
due to inconsistent or incorrect contraceptive use. Credé et al.[3] 
in 2009 also reported that the majority of women had unplanned 
pregnancies, despite a high rate of use of contraception, and with no 
difference according to HIV status.
Unintended pregnancies result in an increase in rates of abortion, 
both legal and illegal. The SA Department of Health reported 
an increase in the rate of abortion, despite the fact that modern 
contra ceptives are available and free in the public sector.[4] Patel 
and Kooverjee[5] also found that the rate of abortion among young 
women in SA has continued to increase despite the availability of 
contraception, and that inconsistent contraceptive use was the main 
reason for unwanted pregnancy. Success in preventing unintended 
pregnancies requires long periods of effective contraceptive use.
Women who choose long-acting methods are least likely to 
experience method failure.[1] The intrauterine contraceptive device 
(IUCD) has an extremely high efficacy rate compared with other 
methods of contraception. The IUCD is not dependent on patient 
participation for correct use, which results in a very low failure 
rate,[6] estimated to be 2 - 3 pregnancies per 100 woman-years.[7]
Recently the SA government has decided to introduce long-acting 
contraceptives, particularly the Cu 380 IUCD, in the public health 
sector. These devices are free in public hospitals and clinics and can 
be inserted at any time, in the immediate postpartum period, after 
abortion or electively when the woman wishes.[8]
Objective
To evaluate knowledge about and attitudes towards the IUCD 
among women in the reproductive age group in a resource-
constrained setting.
Methods
We performed a survey of women attending antenatal/postnatal 
clinics at Northdale Hospital (NDH) and East Boom Community 
Health Centre (CHC) in Pietermaritzburg, SA. Both facilities offer 
maternity services including antenatal, postnatal, prevention of 
mother-to-child transmission of HIV and family planning services.
The study cohort consisted of women attending the public sector 
antenatal/postnatal clinics. Eligible participants were women who 
had attended the antenatal clinic at least once and who had heard 
about different methods of contraception, including the IUCD. 
Participants were excluded if they could not understand English or 
Zulu. They were also excluded if they had never heard of the IUCD. 
One client was excluded because of language and 26 clients because 
they had never heard of the IUCD before.
The sampling was a convenience one, and we interviewed 150 
women in total.
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A brief explanation of the study was given 
to eligible participants and consent was 
obtained from all those who agreed to 
participate.
The researcher administered a structured 
questionnaire. Information on participants’ 
sociodemographic characteristics, previous 
contraceptive methods, knowledge and 
attitudes towards the IUCD and source of 
information was collected from October 
2013 to March 2014. Data were analysed 
using the Statistica data analysis software 
system, version 12 (StatSoft Inc., USA).
Participants were categorised into three 
groups according to their parity. The first 
group (group A) comprised all participants 
who were nulliparous. Group B included 
all participants who were para 1 or 2, 
and group C all those who were para 3 or 
more. The researcher expected women 
with high parity to have better knowledge 
about the device than those with low 
parity. Counselling and information about 
different methods of contraception are 
given to women during each antenatal/
post natal visit.
Summary statistics were estimated for 
all participants. Descriptive results were 
compared by parity status, HIV status and 
facility using the χ2 test. The differences 
between groups were considered significant 
if the p-value was <0.05.
The research was approved by the 
Biomedical Research Ethics Committee 
of the University of KwaZulu-Natal (BE 
302/13), the KwaZulu-Natal Department of 
Health (HRKM 298/13) and the Umgun-




Most participants were in their twenties, 
with a mean age of 25; 76.7% (n=115) were 
<30 years old, 16.0% (n=24) were teenagers, 
and less than 5% (n=7) were aged 35 years 
or more (Table 1).
Most participants were single (69.3%, 
n=104) with only 17.3% (n=26) married 
and 13.3% (n=20) in a stable relationship.
Most participants had some form of 
formal education: 5.3% reported that they 
had never been to school, 52.7% had atten-
ded school up to secondary level, 9.3% 
had only primary school education and 
32.7% had tertiary education. At the time 
of the survey, 52.7% of participants were 
unemployed, 18.7% were still studying and 
28.7% had a job.
Most were HIV-negative (62.7%, n=94). All 
HIV-positive participants except one were 
on antiretroviral therapy at the time of the 
interview (Table 1).
Previous use of contraception 
and  fertility desire
The contraceptive injection was the type of 
contraception with which participants were 
most familiar; 46.0% had some experience 
with contraceptive injections, while only 
2.7% had used the IUCD before, and 
18.0% of participants had used no form of 
contraception before. Condoms alone were 
used as a form of contraceptive method by 
26.0% of participants.
With regard to future plans to conceive, 
of those participants who had a plan, most 
indicated they would like to wait for at least 
3 years before their next pregnancy; 48.7% 
were unsure or had no clear plan at the time 
of the interview (Table 1).
Knowledge about the IUCD
The study showed no significant difference 
among the three parity groups in terms of 
knowledge about the IUCD (p>0.05 for all 
the questions).
All the participants interviewed knew 
that the device is used to prevent pregnancy. 
The majority of them knew that it does 
not protect against HIV, and there was no 
significant difference between the three 
groups regarding their answers. It is of 
concern, however, that some participants 
(29.3%, n=44) could not state with confi-
dence that the device does not prevent 
HIV transmission. Of these 44 participants, 
Table 1. Demographic characteristics and previous experience with contraceptives
Parity group A 
(N=50)
Parity group B 
(N=50)




Age (years), mean 21 24 29 25
Marital status, n (%)
Single 39 (78.0) 35 (70.0) 30 (60.0) 104 (69.3)
Married 2 (4.0) 10 (20.0) 14 (28.0) 26 (17.3)
Stable relationship 9 (18.0) 5 (10.0) 6 (12.0) 20 (13.3)
Education level, n (%)
No schooling 1 (2.0) 2 (4.0) 5 (10.0) 8 (5.3)
Grades 1 - 7 4 (8.0) 2 (4.0) 8 (16.0) 14 (9.3)
Grades 8 - 12 29 (58.0) 24 (48.0) 26 (52.0) 79 (52.7)
Tertiary 16 (32.0) 22 (44.0) 11 (22.0) 49 (32.7)
Employment, n (%)
Unemployed 24 (48.0) 24 (48.0) 31 (62.0) 79 (52.7)
Employed 12 (24.0) 13 (26.0) 18 (36.0) 43 (28.7)
Student 14 (28.0) 13 (26.0) 1 (2.0) 28 (18.7)
HIV status, n (%)
Positive 15 (30.0) 23 (46.0) 18 (36.0) 56 (37.3)
Negative 35 (70.0) 27 (54.0) 32 (64.0) 94 (62.7)
Next pregnancy plan, n (%)
<12 months 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
12 - 24 months 1 (2.0) 1 (2.0) 3 (6.0) 5 (3.3)
25 - 36 months 4 (8.0) 3 (6.0) 2 (4.0) 9 (6.0)
>36 months 23 (46.0) 20 (40.0) 20 (40.0) 63 (42.0)
Unsure 22 (44.0) 26 (52.0) 25 (50.0) 73 (48.7)
Recently used contraceptive, 
n (%)
The Pill 2 (4.0) 4 (8.0) 5 (10.0) 11 (7.3)
Injectable 16 (32.0) 19 (38.0) 34 (68.0) 69 (46.0)
IUCD 1 (2.0) 1 (2.0) 2 (4.0) 4 (2.7)
Condoms 19 (38.0) 14 (28.0) 6 (12.0) 39 (26.0)
None 12 (24.0) 12 (24.0) 3 (6.0) 27 (18.0)
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45.5% (n=20) belonged to group C, 31.8% 
(n=14) to group B and 22.7% (n=10) to the 
nulliparous group (Table 2, Fig. 1). While 
70.7% (n=106) of all participants could tell 
without hesitation that the device does not 
prevent transmission of HIV, there was no 
significant difference when the three groups 
were compared (p=0.086).
Only 40.7% (n=61) of all participants 
knew that HIV-positive women can safely 
use the IUCD. Participants in the group with 
high parity who knew that HIV-positive 
women can also use the device represented 
31.2% (n=19) compared with 36.1% (n=22) 
in the nulliparous group and 32.8% (n=20) 
in group B. The difference between these 
groups was not significant (p=0.82).
Among participants who knew that 
HIV-positive women can use the device 
safely, 59.0% (n=36) were HIV-negative 
and 41.0% (n=25) were HIV-positive. Of 
the 89 participants who said that HIV-
positive women should not use the IUCD, 
65.2% (n=58) were HIV-negative and 34.8% 
(n=31) were HIV-positive.
Of all the participants, 75.3% were 
un certain about whether the IUCD causes 
heavy bleeding. The difference in answers 
between the three groups was significant 
(p=0.03), with more women of high parity 
than nulliparous clients considering the 
device to be a cause of bleeding.
Only 36.7% of the participants (n=55) 
knew that the device does not stop fertility 
indefinitely: 34.6% (n=19) of these women 
belonged to group C, another 34.6% (n=19) 
to group B and 30.9% (n=17) to group A. 
However, the dfference between the groups 
was not significant (p=0.89).
Knowledge about the quick return to 
fertility once the IUCD has been removed 
was very poor. Only 12.0% (n=18) of 
participants answered this question 
correctly; of these 50.0% (n=9) belonged to 
group C, 27.8% (n=5) to group B and 22.2% 
(n=4) to group A. The difference between 
the groups was not significant (p=0.27).
One-third of all participants knew that 
the IUCD can be inserted in the immediate 
postpartum period: 36.0% (n=18) belonged 
to group C, another 36.0% (n=18) to group 
B and 28.0% (n=14) to group A. More 
participants with higher parity than nulli-
parous participants knew that the device 
may be inserted after delivery (p=0.61).
Only 26.7% of the participants (n=40) 
knew that the Cu T380A could be used 
for 10 years. With most women planning 
for their next pregnancy in the next 3 
years, we expected participants to know 
about duration of use, especially those 
in group C. Of these 26.7%, only 27.5% 
(n=11) belonged to group C, 40.0% (n=16) 
to group B and 32.5% (n=13) to group 
A. However, the difference between the 
groups was not statistically significant 
(p=0.52).
When the two facilities included in the 
study were compared, there was a statistical 
difference (p=0.02) in respect of the res ponse 




























Can keep it for up to 10 years
Postpartum insertion
Quick fertility return
Does not stop fertility
Does not cause heavy bleeding
HIV+ women can use it
Does not prevent HIV
Prevents pregnancy
Fig. 1. Knowledge in each parity group. (A = nulliparous; B = para 1 - 2; C = para ≥3.)
Table 2. Knowledge about the IUCD per parity group
Parity group A 
(N=50)
n (%)*
Parity group B 
(N=50)
n (%)*
Parity group C 
(N=50)
n (%)* Total, N p-value
Does not prevent HIV
Know 40 (37.7) 36 (34.0) 30 (28.3) 106 0.08646
Do not know 10 (22.7) 14 (31.8) 20 (45.5) 44
HIV+ women can use IUCD
Know 22 (36.1) 20 (32.8) 19 (31.2) 61 0.82442
Do not know 28 (31.5) 30 (33.7) 31 (34.8) 89
Does not cause heavy bleeding
Know 18 (48.7) 7 (18.9) 12 (32.4) 37 0.03603
Do not know 32 (28.3) 43 (38.1) 38 (33.6) 113
Does not stop fertility
Know 17 (30.9) 19 (34.6) 19 (34.6) 55 0.89094
Do not know 33 (34.7) 31 (32.6) 31 (32.6) 95
Quick fertility return
Know 4 (22.2) 5 (27.8) 9 (50.0) 18 0.27902
Do not know 46 (34.8) 45 (34.1) 41 (31.1) 132
Postpartum insertion 
Know 14 (28.0) 18 (36.0) 18 (36.0) 50 0.61407
Do not know 36 (36.0) 32 (32.0) 32 (32.0) 100
Can keep up to 10 years
Know 13 (32.5) 16 (40.0) 11 (27.5) 40 0.52437
Do not know 37 (33.6) 34 (30.9) 39 (35.5) 110
*Percentages of total answers for each response.
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knew the correct duration of use only 30.0% 
(n=12) were from the clinic compared with 
70.0% (n=28) from the hospital.
In general, knowledge about the IUCD 
among women visiting public sector facilities 
is very poor. Information that should be 
part of every counselling session on contra-
ception, such as the duration of use or the 
time of insertion, as it can influence client 
choice, is ignored. Even among women with 
higher parity knowledge is still poor.
Knowledge was poorer at the East Boom 
CHC compared with NDH. All participants 
knew that the device prevents pregnancy, 
but beyond this information knowledge is 
poor, as shown in Fig. 2.
Attitudes towards the IUCD
Regarding attitudes towards the IUCD, the 
study showed that there are four concerns 
about this type of contraception that need 
to be addressed during every teaching 
and counselling opportunity, namely fear 
of pain, fear of cancer, concern about the 
device’s interfering with sexual activity, and 
fear of womb perforation. Forty percent of 
all partici pants expressed concern about 
pain during insertion, and more than 30% 
expressed fear that having the device in the 
uterus would cause genital cancer and fear 
of womb perforation. The belief that the 
device would interfere with normal sexual 
activity was expressed by more than 30% of 
participants.
Less than 10% of participants would not 
consider using the device because of their 
cultural or religious beliefs.
Twenty-four percent (n=36) of partici-
pants thought that the device was only for 
multiparous women (Table 3).
Almost 21% (n=31) of all participants 
believed their partner would stop using 
condoms if they used the device. This 
concern clearly demonstrates partners’ 
lack of understanding of the reason for the 
continued need for condom use to prev-
ent sexually transmitted diseases. It also 
elucidates the need for couple counselling, 
which may be a challenge to achieve in 
the public sector. In general there were 
some negligible differences among the 
three parity groups, as shown in Table 3, 
except for the issue regarding the fear of 
perforation. More nulliparous participants 
(46.8%) expressed fear of perforation com-
pared with multiparous clients.
Source of information
The main source of information was the 
clinic; 77.3% (n=116) of all participants 
had acquired their information about the 
IUCD from the clinic during teaching and 
counselling sessions. Twelve percent (n=18) 
acquired their information from friends, 
8.0% (n=12) from school, 5.3% (n=8) from 
the media and only 2.7% (n=4) from family 
members. It is worthwhile to note that some 
participants had more than one source of 
information.
Discussion
The study has shown that there is poor 
knowledge about the IUCD among women 
using public sector facilities. There was a 
negligible difference among participants 
based on parity status, contrary to the 
researchers’ expectation that women of 
higher parity might have a good knowledge 
of the long-acting reversible contraceptive 
(LARC) device.
Credé et al.[3] documented poor know-
ledge of LARC methods in their study 
conducted in Cape Town. However, this 
study was done before the government 
embarked on the process of promoting 
the IUCD. Some years down the road, 
knowledge is still poor and uptake of the 
device low. Only 2.7% of participants 
interviewed had used the IUCD before 
and most of them had experience with 
the injectable Depo-Provera. Most parti-
cipants in our study expressed the desire 
to space their children, and were ready 
to wait at least 3 years before their next 
pregnancy, showing a need for LARC 
methods. It seems that clinic staff prefer to 
recommend the injectable method and in 
some situations just prescribe it, especially 
in the postnatal clinics. The study has 
shown a need for the facilities to relook 
at their method of promoting the device, 
especially as the Department of Health 
is in the process of introducing another 
LARC method, i.e. implants (Implanon 
NXT). Following a 12% pregnancy rate 
reported in a study from Swaziland among 
users of Implanon who were HIV-posi-
tive and also taking enzyme-inducing efa-
virenz as antiretroviral therapy,[9] the SA 
government has issued a caution regarding 
Implanon. Although the numbers were 
small, it has at present recommended 
the use rather of Depo-Provera in this 
group, as the increased metabolism of the 
active constituent is not so great (National 
Department of Health circular, available 
on the Southern African HIV Clinicians 
Society home page www.sahivsoc.org).
The participants interviewed were ignor-
ant about most information regarding 
the device. We believe that the facilities 
should make a clear plan to correct this 
situation, as most of this information will 
influence not only uptake of the device 
but also adherence. Nulliparous women 
and those with few children would like to 
be reassured, for example, that the return 
to fertility is relatively quick after removal 
of the IUCD. Very few participants (12%) 
100%
100%
Can keep it for up to 10 years
Postpartum insertion
Quick fertility return
Does not stop fertility
Does not cause heavy bleeding
HIV+ women can use it





















Fig. 2. Knowledge per facility. (* = significant difference.)
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Table 3. Attitudes towards the IUCD per parity group
Parity group A (N=50) 
n (%)*
Parity group B (N=50) 
n (%)*
Parity group C (N=50) 
n (%)* Total, N p-value
Fear partner stops condoms
Agree 10 (32.3) 8 (25.8) 13 (41.9) 31 0.6185
Do not agree 36 (33.3) 37 (34.3) 35 (32.4) 108
No opinion 4 (36.4) 5 (45.5) 2 (18.2) 11
Causes sexually transmitted diseases
Agree 13 (56.5) 5 (21.7) 5 (21.7) 23 0.1060
Do not agree 34 (30.1) 41 (36.3) 38 (33.6) 113
No opinion 3 (21.4) 4 (28.6) 7 (50.0) 14
Interferes with sex
Agree 21 (43.8) 11 (22.9) 16 (33.3) 48 0.2420
Do not agree 26 (28.9) 33 (36.7) 31 (34.4) 90
No opinion 3 (25.0) 6 (50.0) 3 (25.0) 12
Fear of perforation
Agree 22 (46.8) 10 (21.3) 15 (31.9) 47 0.0086
Do not agree 27 (31.8) 30 (35.3) 28 (32.9) 85
No opinion 1 (5.6) 10 (55.6) 7 (38.9) 18
Fear of cancer
Agree 22 (44.0) 11 (22.0) 17 (34.0) 50 0.1481
Do not agree 23 (26.1) 35 (39.8) 30 (34.1) 88
No opinion 5 (41.7) 4 (33.3) 3 (25.0) 12
Fear of pain
Agree 21 (35.0) 17 (28.3) 22 (36.7) 60 0.7511
Do not agree 26 (33.3) 29 (37.2) 23 (29.5) 78
No opinion 23 (25.0) 4 (33.3) 5 (41.7) 12
Only for multiparous
Agree 11 (30.6) 12 (33.3) 13 (36.1) 36 0.9738
Do not agree 36 (34.6) 35 (33.7) 33 (31.7) 104
No opinion 3 (30.0) 3 (30.0) 4 (40.0) 10
Fear of gaining weight
Agree 10 (27.8) 14 (38.9) 12 (33.3) 36 0.3014
Do not agree 38 (38.0) 29 (29.0) 33 (33.0) 100
No opinion 2 (14.3) 7 (50.0) 5 (35.7) 14
It is like abortion
Agree 2 (18.2) 4 (36.4) 5 (45.5) 11 0.1957
Do not agree 48 (35.0) 46 (33.6) 43 (31.4) 137
No opinion 0 0 2 (100.0) 2
It is a sin
Agree 2 (22.2) 3 (33.3) 4 (44.4) 9 0.5762
Do not agree 47 (33.6) 47 (35.6) 46 (32.9) 140
No opinion 1 (100.0) 0 0 1
Religion is against
Agree 3 (21.4) 7 (50.0) 4 (28.6) 14 0.4482
Do not agree 47 (35.1) 42 (31.3) 45 (33.6) 134
No opinion 0 1 (50.0) 1 (50.0) 2
Tradition is against
Agree 4 (28.6) 4 (28.6) 6 (42.9) 14 0.7376
Do not agree 46 (33.8) 46 (33.8) 44 (32.4) 136
No opinion 0 0 0 0
*Percentages of total answers for each response.
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knew this fact. This finding was similar to that of Credé et al.[3] in 
Cape Town. This may negatively affect uptake, not only among 
women of low parity but also among those who are advanced in age. 
Clinics should ensure that issues regarding fertility return are dealt 
with during counselling, to improve uptake of the device.
Most women interviewed would like to wait for at least 3 years 
before their next pregnancy. We believe that they would like to 
know for how long it is safe to have a foreign body inserted in their 
uterus. Unfortunately only 26.7% of women interviewed knew that 
it is actually safe to use the IUCD for up to 10 years. Credé et al.[3] 
found that more than half of their participants did not know that 
they could use the device for 10 years. Studies conducted in SA by 
Gutin et al.[10] and in the USA by Whitaker et al.[11] reported that 
participants mentioned as an advantage the fact that the IUCD 
could be used for a long time.
With the high prevalence of HIV in SA, and particularly in 
KwaZulu-Natal, the researchers expected that most women, 
regardless of their HIV status, would know that HIV-positive 
women can safely use the IUCD. Only 41.0% of all participants 
knew that HIV patients can safely use it. Credé et al.[3] reported that 
more than half of their participants did not know that HIV-positive 
patients could safely use the IUCD. In our study, only 44.6% of HIV-
positive women knew that it was safe for them to use the device, and 
38.3% of HIV-negative participants knew that HIV-positive women 
can use it. It is also crucial to inform women that, unlike barrier 
contraceptives, IUCDs do not provide protection against HIV or 
other sexually transmitted diseases.[7]
We believe one of the ways to improve the situation is to prepare 
a structured teaching presentation on contraception including all 
these facts to be used as a template. Clinics should refrain from 
prescribing one type of contraceptive; women should be allowed 
to choose freely after discussion of appropriate information. In 
fact, according to the World Health Organization’s evidence-
based medical eligibility criteria for contraceptive use, LARC 
methods have few contraindications. Because of this and the 
potential to reduce unintended pregnancy rates, the American 
Congress of Obstetricians and Gynecologists suggests that LARC 
methods should be offered as first-line contraceptive methods and 
encouraged as options for most women.[12]
There were few misconceptions about the IUCD as documented 
in the results above. Gutin et al.[10] also found that there was 
poor knowledge about the IUCD among SA women but few 
misconceptions. Neither religion nor traditional beliefs seem to 
be an obstacle when it comes to the use of the IUCD. The only 
elements that seem to be of concern are fear of pain, fear of cancer, 
fear of womb perforation and interference with sexual activity, 
even though none of these was an issue in more than 40% of the 
participants. These concerns should be addressed during every 
counsel ling session if we expect to improve uptake of the device.
The answers from the hospital group showed greater knowledge 
and more accurate attitudes about IUCDs than those from the 
clinic group. The difference was significant in some cases, as shown 
in Fig. 2. This may be explained by the fact that the clinic had not 
yet started offering insertion of the IUCD and were referring their 
clients to the hospital.
Most of the participants (77.3%) acquired their knowledge from 
the clinic, indicating the need for the facilities to ensure that the 
information they are transmitting is comprehensive. None of the 
participants mentioned the leaflet as a source of information. The 
clinics should perhaps try to use leaflets in addition to the usual 
form of teaching. The advantage of this is that the leaflet can be 
taken at home and be shared with the partner/family, especially 
in an environment where men do not attend family planning 
clinics. Partner/family disapproval can influence uptake and reduce 
adherence.[13,14]
Study limitations and strengths
The findings of this study are based on a convenience sample of 
women from a specific area, Pietermaritzburg. The trans ferability 
of the results may therefore be limited. However, the study gave 
us a picture of the current situation in the public sector in this 
area.
This is the first study to investigate attitudes and knowledge about 
the IUCD among clients in this area. It has identified the main 
misconceptions among clients and showed that knowledge among 
clients is poor. The findings should be used by clinics to improve the 
situation.
Conclusion
This survey documents poor knowledge about the IUCD among 
women using the public health sector in Pietermaritzburg, SA. A 
notable finding of our study was fewer misconceptions compared 
with those documented in studies conducted in other parts of 
the country. This finding, coupled with the fact that most of the 
participants rely on the clinic as their source of information, should 
be seen as an opportunity to improve the situation. Diversification 
of methods of teaching and the involvement of the partner/family, 
either through direct contact or via documents such as leaflets, may 
help in terms of the uptake of the device and adherence.
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